In the HCC tumor microenvironment, M2-TAMs promote tumorigenesis by enhancing proliferation, invasion, metastasis, and angiogenesis; they also suppress anti-tumor immunity by inhibiting the functions of CD4+ T cells and CD8+ T cells (36). Here, CD8A is linked to hepatocellular carcinoma.